VCP Scanner
Stock Screener
Filter stocks with fundamental & technical criteria
Market Themes
Curated industry baskets & thematic leaders
Earnings Hub
Calendar, EPS surprise stats & earnings transcripts
Market News
Real-time market intelligence & AI overviews
Insider Buying
SEC Form 4 corporate insider purchases
MinerviniVCP SetupsTrend Template
O'NeilCup with HandleFlat BaseDouble BottomCANSLIM Leaders
QullamaggieHigh Tight FlagsFlag BreakoutsEpisodic PivotsMomentum Leaders
KellWedge PopEMA Crossback
LivermorePivotal Points
PatternsFalling Wedge & ChannelBase Breakouts
View All Playbooks...
BreakoutsScanner
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Index & ETFs
SPY vs QQQVTI vs VOOSPY vs IWM
Compare Any Stocks...
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
VisualizeInteractive multi-year financial charts
Watchlist
BreakoutsScanner
WatchlistPricing
Ctrl K
Pricing
CLPT
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Analyze deeply. Research with clarity.

Data updated daily

Product

  • Screener
  • Scanner
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • Pricing
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly market insights — free

© 2026 VCP Scanner
AboutPrivacyTermsRefund Policy
Not financial advice. Do your own research.
ScreenerBreakoutsScannerWatchlist
CLPTClearPoint Neuro, Inc.
$8.60$258M
Overview & Tools
OverviewChart Terminal ↗Visualize
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice History
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Discovery & Screens
Live BreakoutsStock ScreenerOwnership
CLPT logo

ClearPoint Neuro, Inc.

CLPT
NASDAQ · Medical Devices
$8.60
At close - Nov 6, 4:00 PM EST - USD
Market Cap$258M
P/E-7.4x
52W High$19.63
Volume945.86K
OverviewTerminalAnalysisFinancialsValuationEarningsBreakoutsOwnership
VCP Research Verdict2026Q3

Revenue Rebound Still Overshadowed by Persistent Cash Burn

ClearPoint Neuro's revenue has rebounded sharply, with 2026Q3 sales reaching $12.1M, up 36.3% year over year, and gross margins holding in a 58% to 64% band.

GrowthMixed
ProfitabilityNegative
ValuationReview
TechnicalsWeak
Explore valuation models
MARKET ACTION

CLPT price & volume

Price trend, volume and key moving averages

Launch Terminal
Loading chart...
Decision Checklist4 Core Signals

What matters now

The signals most likely to change the investment case.

01

Earnings momentum

4/12 Beats

EPS beat 4 of last 12 quarters

02

Valuation risk

-121% Peers

P/E is 121% below peer median

03

Market leadership

RS 18 · Lag

Laggard (Underperforming 82% of market)

04

Weak Trend

Below 200DMA

Price < 200DMA

Next CatalystEstimated earnings · Jan 28

Market performance

Price History →

Trailing total returns as of 11/8/2026, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC).

YTD Return
CLPT-38.70%
S&P 500 (^GSPC)+7.63%
1-Year Return
CLPT-52.83%
S&P 500 (^GSPC)+9.69%
3-Year Return
CLPT+43.09%
S&P 500 (^GSPC)+67.10%
5-Year Return
CLPT-53.54%
S&P 500 (^GSPC)+55.52%

Growth & profitability

Annual revenue & EPS trend
Revenue FY25
$37M+17.8% YoY
Net income FY25
-$26M-35.0% YoY
Free cash flow FY25
-$24M-165.0% YoY
Operating margin FY25
-65.4%-2.5 pts YoY
ROIC (FY25)-73.7%
Avg ROIC 5Y-110.8%
ROE (TTM)-170.2%
Piotroski Score4 / 9
Financial Statements →
03

Monitor what changed

Recent results and news deserve attention only when they alter the forward view.

OPERATING RESULTS

Recent Earnings

Earnings History
EPS Beat Rate4/12 (33%)
Revenue Beat Rate6/12 (50%)
QuarterEPS (Act vs Est)Revenue (Act vs Est)
Q4 2026Latest
Oct 28, 2026
-$0.24+23.8%
vs -$0.32
$12M-1.8%
vs $12M
Q3 2026
Aug 3, 2026
-$0.38-32.6%
vs -$0.29
$11M-14.6%
vs $13M
Q2 2026
May 13, 2026
-$0.32-14.3%
vs -$0.28
$12M+1.3%
vs $12M
Q2 2026
Mar 17, 2026
-$0.27-22.7%
vs -$0.22
$10M+3.5%
vs $10M
Historical baseline: 12 quarters analyzedGAAP / Adjusted
MARKET COVERAGE

Latest News

2 Stories
Accesswire·Oct 14, 2026
ClearPoint Neuro to Announce Third Quarter 2026 Results October 28, 2026

SOLANA BEACH, CA / ACCESS Newswire / October 14, 2026 / ClearPoint Neuro, Inc. (NASDAQ:CLPT) (the "Company"), a global device, cell, and gene therapy-enabling company offering precise navigation to the brain and spine, today announced that it will release financial results for its 2026 third quarter on Wednesday, October 28, 2026, after the market close. Investors and analysts are invited to listen to the live broadcast review of the Company's 2026 third quarter on Wednesday, October 28 at 4:30 p.m.

Seeking Alpha·Oct 7, 2026
Cedar Grove Capital Q3 2026 Portfolio Update

During the quarter, we closed our long positions in MTY Food Group, uniQure, ClearPoint Neuro, and Suja Life Inc. During the quarter, we closed short positions in Bending Spoons SpA, Chipotle Mexican Grill, The Ensign Group, Gemini Space Station, Jersey Mike's Subs, Moderna, Reformation, Once Upon a Farm, and X-Energy Inc. We initiated a small tracking position in Zedcor Inc. while continuing our due diligence.

Filtered for ClearPoint Neuro, Inc.More Headlines
04

Compare before deciding

Benchmark CLPT against direct peers instead of judging its metrics in isolation.

Peers Comparison

Key metrics vs top competitors for ClearPoint Neuro, Inc. (CLPT)

Full Screener →
CompanyPriceMarket CapP/E RatioRev Growth (1Y)Net MarginROEDiv Yield
CLPT logoCLPTClearPoint Neuro, Inc.Current
$8.60$257.91M-7.3717.78%-79.43%-170.24%—
NVCR logoNVCRNovocure Ltd
$13.28$1.54B-12.748.28%-16.78%-35.81%—
INVA logoINVAInnoviva, Inc.
$19.10$1.41B7.1218.52%43.79%15.84%—
ABT logoABTAbbott Laboratories
$109.93$191.48B40.645.67%9.75%9%2.14%
MDT logoMDTMedtronic plc
$101.80$130.7B25.018.43%13.93%10.51%2.78%
ANGO logoANGOAngioDynamics, Inc.
$11.73$484.83M-14.979.46%-10.12%-19.25%—

Compare CLPT vs Peers

ClearPoint Neuro, Inc. (CLPT) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.

Closest Rival

vs NVCR

Most directly comparable listed peer for CLPT.

Scale Benchmark

vs GE

Larger-name benchmark to compare CLPT against a more recognizable public peer.

Peer Set

Compare Top 5

vs NVCR, INVA, ABT, MDT

05

Keep researching

Verify the primary filings, follow material updates, and answer the remaining questions.

CLPT SEC Filings & Documents

ClearPoint Neuro, Inc. (CLPT) SEC filings — annual & quarterly reports (10-K, 10-Q)

8-K Announcements

6
Material company update

Oct 28, 2026·SEC

Material company update

Aug 3, 2026·SEC

Material company update

May 21, 2026·SEC

10-K Annual Reports

3
FY 2026

Mar 17, 2026·SEC

FY 2025

Feb 26, 2025·SEC

FY 2024

Mar 12, 2024·SEC

10-Q Quarterly Reports

6
FY 2026

Oct 28, 2026·SEC

FY 2026

Aug 3, 2026·SEC

FY 2026

May 13, 2026·SEC

Get notified when CLPT posts new earnings or crosses analyst targets

Free. No account needed. Unsubscribe any time.

Free. Unsubscribe any time.

CLPT Frequently Asked Questions

ClearPoint Neuro, Inc. (CLPT) stock FAQ — growth, dividends, profitability & financials explained

Growth & Financials
What is ClearPoint Neuro, Inc.'s revenue?

ClearPoint Neuro, Inc. (CLPT) reported $45.5M in revenue over the trailing twelve months. Revenue was $37.0M in fiscal year 2025. That is 868% more than the $3.8M of fiscal year 2011.

How fast is ClearPoint Neuro, Inc. growing?

ClearPoint Neuro, Inc. (CLPT) grew revenue by 32.5% over the trailing twelve months, compared with the twelve months before.

Is CLPT profitable?

No. ClearPoint Neuro, Inc. (CLPT) reported a net loss of $36.1M over the trailing twelve months.

Dividend & Returns
What is CLPT's return on equity?

ClearPoint Neuro, Inc. (CLPT) had a return on equity (ROE) of -170.2% over the trailing twelve months. A negative ROE means the company lost money over the period.

What is ClearPoint Neuro, Inc.'s free cash flow?

ClearPoint Neuro, Inc. (CLPT) had negative free cash flow of $33.2M over the trailing twelve months.

What if you invested $1,000 in CLPT back in 2011?

Total return calculator · dividends reinvested · 15+ years of data

See returns →